tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Day One Biopharma Reports Strong Q2 2025 Growth
PremiumCompany AnnouncementsDay One Biopharma Reports Strong Q2 2025 Growth
3d ago
Day One Biopharmaceuticals Reports Strong Q2 2025 Results
Premium
Company Announcements
Day One Biopharmaceuticals Reports Strong Q2 2025 Results
3d ago
Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)
Premium
The Fly
Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)
3d ago
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
PremiumRatingsPromising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
2M ago
Day One Biopharma’s Earnings Call Highlights Growth
Premium
Company Announcements
Day One Biopharma’s Earnings Call Highlights Growth
3M ago
Day One price target lowered to $26 from $30 at JonesResearch
Premium
The Fly
Day One price target lowered to $26 from $30 at JonesResearch
3M ago
Day One Biopharmaceuticals Reports Strong Q1 2025 Results
PremiumCompany AnnouncementsDay One Biopharmaceuticals Reports Strong Q1 2025 Results
3M ago
Positive Growth Outlook for Day One Biopharmaceuticals Driven by Strong Q1 Performance and Strategic Initiatives
Premium
Ratings
Positive Growth Outlook for Day One Biopharmaceuticals Driven by Strong Q1 Performance and Strategic Initiatives
3M ago
Day One Biopharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Day One Biopharmaceuticals Reports Q1 2025 Financial Results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100